Shigetada Teshima-Kondo Selected Research

Shigetada Teshima-Kondo Research Topics

Disease

10	Neoplasms (Cancer) 11/2019 - 09/2006
7	Colonic Neoplasms (Colon Cancer) 11/2019 - 03/2004
7	Inflammation (Inflammations) 01/2015 - 02/2005
6	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 05/2013
4	Muscular Atrophy (Muscle Atrophy) 01/2018 - 01/2013
3	Infections 01/2021 - 09/2006
3	Hypoxia (Hypoxemia) 01/2015 - 05/2013
3	Obesity 01/2014 - 11/2009
3	Carcinogenesis 07/2008 - 09/2006
2	Lymphoma (Lymphomas) 01/2018 - 01/2014
2	Disease Progression 01/2017 - 01/2015
2	Insulin Resistance 01/2016 - 01/2014
2	Atrophy 03/2015 - 01/2015
1	Influenza in Birds (Avian Flu) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Overweight 11/2009
1	Stomach Neoplasms (Stomach Cancer) 08/2009
1	Colitis 01/2009
1	Adenoma (Adenomas) 12/2007
1	Adenocarcinoma 12/2007
1	Carcinoma (Carcinomatosis) 12/2007
1	Atrophic Gastritis 12/2007
1	Ulcer 02/2005
1	Hyperglycemia 10/2004
1	Vascular Diseases (Vascular Disease) 10/2004

Drug/Important Bio-Agent (IBA)

8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 05/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2006
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 05/2013
5	Messenger RNA (mRNA)IBA 01/2009 - 10/2004
4	UbiquitinIBA 01/2018 - 01/2013
4	Ligases (Synthetase)IBA 01/2018 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2013 - 03/2004
3	Angiogenesis InhibitorsIBA 01/2017 - 01/2015
3	Oxidoreductases (Dehydrogenase)IBA 01/2009 - 12/2007
2	Tyrosine Kinase InhibitorsIBA 04/2018 - 01/2015
2	Sunitinib (Sutent)FDA Link 04/2018 - 01/2017
2	regorafenibIBA 01/2017 - 01/2015
2	Monoclonal AntibodiesIBA 01/2015 - 05/2013
2	Peptides (Polypeptides)IBA 01/2013 - 12/2007
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2008 - 09/2006
2	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2007 - 03/2004
1	SARS-CoV-2 spike proteinIBA 01/2021
1	tetrapeptide carbamateIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	TrypsinIBA 01/2021
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021
1	FurinIBA 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2019
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2019
1	ErbB Receptors (EGF Receptor)IBA 11/2019
1	Epidermal Growth Factor (EGF)IBA 11/2019
1	Neuropilin-1IBA 04/2018
1	Bevacizumab (Avastin)FDA Link 04/2018
1	LigandsIBA 01/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Uncoupling Protein 3IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	LipidsIBA 01/2016
1	pyruvate dehydrogenase kinase 4IBA 01/2016
1	GlucocorticoidsIBA 03/2015
1	FlavonoidsIBA 01/2015
1	Vascular Endothelial Growth Factor BIBA 01/2015
1	ApigeninIBA 01/2015
1	Soybean Proteins (Soy Protein)IBA 01/2015
1	FlavonesIBA 01/2015
1	GSK 1363089IBA 01/2015
1	LuteolinIBA 01/2015
1	CytokinesIBA 01/2014
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2014
1	Insulin (Novolin)FDA Link 06/2013
1	glycininIBA 01/2013
1	arseniteIBA 08/2009
1	Protein Isoforms (Isoforms)IBA 08/2009
1	Interleukin-10 (Interleukin 10)IBA 01/2009
1	Superoxides (Superoxide)IBA 12/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2008
1	Interleukin-1beta (Interleukin 1 beta)IBA 12/2008
1	FlagellinIBA 12/2008
1	Interferon-gamma (Interferon, gamma)IBA 12/2008
1	Etoposide (VP 16)FDA LinkGeneric 05/2008
1	Fluorouracil (Carac)FDA LinkGeneric 05/2008
1	5' Untranslated Regions (5' UTR)IBA 05/2008
1	Small Interfering RNA (siRNA)IBA 05/2008
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	InterferonsIBA 05/2008
1	NADPH Oxidase 1IBA 12/2007
1	MucinsIBA 12/2007
1	Helicobacter pylori lipopolysaccharideIBA 09/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2006
1	ecabetIBA 02/2005
1	Internal Ribosome Entry SitesIBA 10/2004
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2004
1	NADP (NADPH)IBA 03/2004

Therapy/Procedure

7	Therapeutics 04/2018 - 05/2008
1	Denervation 01/2013
1	Caloric Restriction 11/2009